Vyvdura receives Japanese regulatory approval for adults with chronic inflammatory demyelinating polyneuropathy: Rotterdam, the Netherlands Monday, December 30, 2024, 1 ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...
StemCyte announces positive results from phase IIa trial of HPC, cord blood for treating post-Covid syndrome: Baldwin Park, California Monday, December 23, 2024, 17:00 Hrs [IST] S ...